The peptide market sits at a crossroads that regulators, payment processors, and financial institutions are closely watching. A product marketed as a dietary supplement and the same compound sold for "research use only" may contain identical molecules — but they exist in entirely different regulatory worlds, and the consequences of misclassifying one as the other […]

The Food and Drug Administration issued an urgent consumer alert in September 2025 after discovering counterfeit dietary supplements containing a hidden prescription drug. The fake products, misrepresented as authentic Green Lumber supplements for men, were found to contain tadalafil—a prescription medication used to treat erectile dysfunction—creating serious health risks for unsuspecting consumers. According to the […]

San Francisco-based Evolv has launched a dietary supplement containing a peptide designed to engage GLP-1 and GIP receptors, positioning the product in what the company calls a "biomimetics" category between traditional supplements and prescription medications like Ozempic. Engineered Yeast Platform The supplement contains baker's yeast engineered to produce a peptide that interacts with GLP-1 and […]

Last month, the US Food and Drug Administration (FDA) published final guidance designed to help sponsors identify appropriate supplement categories for biosimilar prior approval supplements. The guidance establishes six distinct categories and outlines the agency's review goals for each, fulfilling a commitment made in the Biosimilar User Fee Amendments of 2022 (BsUFA III) commitment letter. […]